Sorafenib in Thyroid Cancer Patients: Learning From Toxicity In Reply

被引：0
|
作者：
Cabanillas, Maria E. [1 ]
Dadu, Ramona [1 ]
Lai, Stephen Y. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, Houston, TX 77030 USA
来源：
ONCOLOGIST | 2014年 / 19卷 / 08期
关键词：
D O I：
10.1634/theoncologist.2014-0186
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E4 / E4
页数：1
相关论文
共 50 条
  • [21] Efficacy of sorafenib and impact on cardiac function in patients with thyroid cancer: a retrospective analysis
    L. Mortara
    G. Pera
    E. Monti
    S. Morbelli
    F. Minuto
    G. Sambuceti
    M. Giusti
    Journal of Endocrinological Investigation, 2014, 37 : 1099 - 1108
  • [22] Efficacy of sorafenib and impact on cardiac function in patients with thyroid cancer: a retrospective analysis
    Mortara, L.
    Pera, G.
    Monti, E.
    Morbelli, S.
    Minuto, F.
    Sambuceti, G.
    Giusti, M.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2014, 37 (11) : 1099 - 1108
  • [23] Efficacy and Tolerability of Different Starting Doses of Sorafenib in Patients With Differentiated Thyroid Cancer
    Dadu, Ramona
    Waguespack, Steven G.
    Sherman, Steven I.
    Hu, Mimi I.
    Busaidy, Naifa L.
    Jimenez, Camilo
    Habra, Mohammed A.
    Ying, Anita K.
    Bassett, Roland L.
    Cabanillas, Maria E.
    ONCOLOGIST, 2014, 19 (05): : 477 - 482
  • [24] Sorafenib in thyroid cancer—a retrospective case series
    Gabriele Gamerith
    Andreas Pircher
    Arno Amann
    Katharina Cima
    Klaus Gasser
    Markus Lenzhofer
    Peter Lind
    Evelyne Bareck
    Ewald Wöll
    Wolfgang Hilbe
    memo - Magazine of European Medical Oncology, 2012, 5 (3) : 246 - 249
  • [25] Financial toxicity in a large cohort of thyroid cancer patients: An analysis from the North American Thyroid Cancer Survivorship study.
    De Souza, Jonas A.
    Grogan, Raymon
    Kircher, Sheetal Mehta
    Aschebrook-Kilfoy, Brisa
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [26] Sorafenib in Metastatic Thyroid Cancer: A Systematic Review
    Thomas, Ligy
    Lai, Stephen Y.
    Dong, Wenli
    Feng, Lei
    Dadu, Ramona
    Regone, Rachel M.
    Cabanillas, Maria E.
    ONCOLOGIST, 2014, 19 (03): : 251 - 258
  • [27] Selective use of sorafenib in the treatment of thyroid cancer
    Pitoia, Fabian
    Jerkovich, Fernando
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 1119 - 1131
  • [28] Aggressive thyroid cancer: targeted therapy with sorafenib
    Corrado, Alda
    Ferrari, Silvia M.
    Politti, Ugo
    Mazzi, Valeria
    Miccoli, Mario
    Materazzi, Gabriele
    Antonelli, Alessandro
    Ulisse, Salvatore
    Fallahi, Poupak
    Miccoli, Paolo
    MINERVA ENDOCRINOLOGICA, 2017, 42 (01) : 64 - 76
  • [29] The discovery and development of sorafenib for the treatment of thyroid cancer
    White, Peter T.
    Cohen, Mark S.
    EXPERT OPINION ON DRUG DISCOVERY, 2015, 10 (04) : 427 - 439
  • [30] Sorafenib for the treatment of thyroid cancer: an updated review
    Krajewska, Jolanta
    Handkiewicz-Junak, Daria
    Jarzab, Barbara
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (04) : 573 - 583
12345